Cadaver kidney allograft survival in a high-risk black population utilizing antilymphoblast globulin and low steroid therapy.
This study contrasts graft and patient survival in black and white high-risk populations receiving cadaveric renal allografts. In addition, factors affecting the outcome of black and white high-risk patients maintained on chronic hemodialysis for one year are studied. While immunosuppression and treatment of rejection with ALG appeared to improve graft and patient survival of both black and white allograft recipients, high-risk black patients tended to do poorly on chronic hemodialysis. Black high-risk patients, therefore, may be better candidates for transplantation.
D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D044383:Black People; D002102:Cadaver; D006085:Graft Survival / Q000187:drug effects*; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use*; D006435:Renal Dialysis / Q000009:adverse effects; D012189:Retrospective Studies; D012306:Risk; D044465:White People
D000961:Antilymphocyte Serum; D011239:Prednisolone; D001379:Azathioprine